2017 AAOS Annual Meeting: Triamcinolone vs. Dexamethasone Injection for Trigger Finger: A Randomized Controlled Trial

69 patients with trigger finger were randomized to treatment with either triamcinolone injection or dexamethasone injection. Patients were followed up at 6 weeks, 12 weeks, and 6 months for symptom resolution. Repeat injections were offered in cases of persistent or recurrent symptoms. During follow-up, fewer patients of the triamcinolone group required repeat injection compared to the dexamethasone group. At final follow-up, significantly more patients in the triamcinolone group demonstrated symptom resolution and fewer patients required surgery when compared to the dexamethasone group.